New Brigham–Wyss Diagnostic Accelerator could enable fast creation of diagnostic technologies
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston s Brigham and Women Hospital (Brigham) announce their newly founded Diagnostic Accelerator (Brigham-Wyss DxA). By combining the institutions broad clinical and multi-disciplinary bioengineering expertise, the Brigham-Wyss DxA will enable the fast creation of diagnostic technologies through deep collaborations in a process driven by previously unmet needs.
The Brigham-Wyss DxA presents a new type of research collaboration with the potential to significantly compress the timeframe for introducing new diagnostic technologies specifically developed to solve high-value clinical problems. The collaborators plan to achieve this through a formal process by which unmet diagnostic challenges are identified by the Brigham clinical community, effectively matched with highly appropriate technologies crea
FIND Cell is a new tool that digitizes cell culture to enable reproducible biomedical science
New cloud based software platform reduces research costs and improves speed and reliability
News provided by
Share this article
Share this article
NEW YORK, May 19, 2021 /PRNewswire/ Lack of reproducibility is a critical problem in biomedical science, wasting both time and billions of dollars every year. The Correspondence
Tracking cell lineages improves research reproducibility , published today in Nature Biotechnology, lays the scientific foundation for a brand-new software platform called
FIND Cell; a unique tool that aims to improve reproducibility of cell-based science.
FIND Cell (available at https://findgen.bio/) integrates daily cell line tracking with genetic verification. It enables scientists to digitize, organise, verify, and find their cell culture related information – which is critical for biomedical research.
Novel integrative genetic screening platform offers insights into role of DNA accessibility in cancer
In a new resource for the scientific community, published today in
Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) developed CRISPR-sciATAC, a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide.
With this technology, they profile changes in genome organization and create a large-scale atlas of how loss of individual chromatin-altering enzymes impacts the human genome. The new method harnesses the programmability of the gene editing system CRISPR to knock-out nearly all chromatin-related genes in parallel, offering researchers deeper insights into the role of DNA accessibility in cancer and in rare diseases involving chromatin.
E-Mail
IMAGE: CRISPR-sciATAC is a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. The new method harnesses the programmability of the gene editing system. view more
Credit: Sanjana Lab of New York Genome Center and NYU
NEW YORK, NY (April 29, 2021) - In a new resource for the scientific community, published today in
Nature Biotechnology, researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center (NYGC) and New York University (NYU) developed CRISPR-sciATAC, a novel integrative genetic screening platform that jointly captures CRISPR gene perturbations and single-cell chromatin accessibility genome-wide. With this technology, they profile changes in genome organization and create a large-scale atlas of how loss of individual chromatin-altering enzymes impacts the human genome. The new method harnesses the programmability of the gene editing system CRISP
Meet the Team: Patricia Cortes, Human Capital Initiative | Global Development Policy Center bu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bu.edu Daily Mail and Mail on Sunday newspapers.